CD4 and non-small cell lung carcinoma: A positive relationship was observed between a heightened density of CD4+ TILs and enhanced OS in patients with NSCLC (HR=0.90, 95%CI: 0.77-1.05, P>0.05, Figure 7A), with significant heterogeneity (I2 = 39.2%, P=0.065).